Literature DB >> 23108752

Ectopic Cushing's syndrome caused by a pulmonary ACTH-secreting tumor in a patient treated with octreotide.

Pedro Rodrigues1, José Luís Castedo, Margarida Damasceno, Davide Carvalho.   

Abstract

Ectopic ACTH syndrome is a rare disease often associated with severe hypercortisolism. When feasible, optimal management is surgical excision of the tumor. A 33-year-old male patient was admitted to the hospital in 1993 with clinical manifestations suggestive of Cushing's syndrome. He presented high plasma ACTH and markedly elevated urinary free cortisol excretion that was not suppressed with high-dose dexamethasone administration. Pituitary MRI scan was normal. No central-to-peripheral ACTH gradient was present in bilateral inferior petrosal sinus sampling. Thoracic CT scan showed a 1.7 cm nodule at the left lung. Pulmonary fine needle cytology and immunocytochemical and ultrastructural studies, together with the presence of bone metastases, led to the diagnosis of an ACTH-producing neuroendocrine carcinoma. He was initially submitted to chemotherapy and has been on treatment with octreotide LAR since 1998, having shown a favorable clinical, biochemical and imaging response. We highlight the excellent long-term response to medical therapy with octreotide LAR, without tachyphylaxis, probably due to its antiproliferative effect.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108752     DOI: 10.1590/s0004-27302012000700009

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  4 in total

Review 1.  Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review.

Authors:  Andrea M Isidori; Emilia Sbardella; Maria Chiara Zatelli; Mara Boschetti; Giovanni Vitale; Annamaria Colao; Rosario Pivonello
Journal:  J Clin Endocrinol Metab       Date:  2015-09       Impact factor: 5.958

2.  Adrenocorticotropic Hormone-Dependent Cushing's Syndrome: Use of an octreotide trial to distinguish between pituitary or ectopic sources.

Authors:  Omayma T El-Shafie; Nooralddin Al-Saffi; Ahmed Al-Sajwani; Nicholas Woodhouse
Journal:  Sultan Qaboos Univ Med J       Date:  2015-01-21

3.  Follistatin is a novel biomarker for lung adenocarcinoma in humans.

Authors:  Fangfang Chen; Ping Ren; Ye Feng; Haiyan Liu; Yang Sun; Zhonghui Liu; Jingyan Ge; Xueling Cui
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

4.  Ectopic Cushing's Syndrome Unveiling a Metastatic Parotid Carcinoma.

Authors:  Sofia Castro Oliveira; João Sérgio Neves; Pedro Souteiro; Sandra Belo; Ana Isabel Oliveira; Helena Moreira; Paulo Mergulhão Gomes; Lígia Coelho; Cristina Sarmento; Elsa Fonseca; Celestino Neves; Paula Freitas; Davide Carvalho
Journal:  Case Rep Endocrinol       Date:  2019-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.